CD370 (CLEC9A) Antibody, anti-mouse, Biotin 130-101-877 from Miltenyi Biotec | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Miltenyi Biotec for
CD370 (CLEC9A) Antibody, anti-mouse, Biotin

Miltenyi Biotec's CD370 (CLEC9A) Antibody, anti-mouse, Biotin is a Rat monoclonal antibody. The CD370 (CLEC9A) Antibody, anti-mouse, Biotin was generated using CLEC9A as the antigen. It reacts with Mouse. This antibody has been shown to work in applications such as: Flow Cytometry.

Product Specs
ItemCD370 (CLEC9A) Antibody, anti-mouse, Biotin
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-101-877
Quantity30 µg in 1 mL
ApplicationsFlow cytometry
Conjugate/TagBiotin
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Reactivitymouse
TargetCD370 (CLEC9A)
IsotypeIgG1
Clone7H11
Hostrat
Antibody TypePrimary antibodies
NCBI Full Gene NameC-type lectin domain family 9, member a
NCBI Gene Aliases9830005G06Rik, DNGR, DNGR-1
Clonalitymonoclonal
Regulatory StatusFor research use only
Concentration1:10
Research AreaFor research use only

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9AEuropean journal of immunologyMay 1, 2010Joffre OP, Sancho D, Zelenay S, Keller AM, Reis e Sousa C.

(2) Identification of a dendritic cell receptor that couples sensing of necrosis to immunityNatureApril 16, 2009Sancho D, Joffre OP, Keller AM, Rogers NC, Martínez D, Hernanz-Falcón P, Rosewell I, Reis e Sousa C.

(3) Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectinThe Journal of clinical investigationJune 1, 2008Sancho D, Mourão-Sá D, Joffre OP, Schulz O, Rogers NC, Pennington DJ, Carlyle JR, Reis e Sousa C.

Be the First to Write a Review!